KMT2A and acute lymphoblastic leukemia: An aberrantly increased H3K79me3 mark is one of the main hallmarks of KMT2A-rearranged BCP-ALL, a process occurring through the altered activity of the DOT1L enzyme, which is recruited to proximal transcribed regions of active genes [28,80,81].